(Q40513472)

English

Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement

scientific article published on October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement (English)

1 reference

Europe PubMed Central

21 September 2017

1 reference

based on heuristic

inferred from title

membrane protein

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

4

object named as

Bernard Moss

1 reference

Europe PubMed Central

21 September 2017

Christiana N Fogg

2

object named as

Christiana Fogg

1 reference

Europe PubMed Central

21 September 2017

author name string

Shlomo Lustig

1

1 reference

Europe PubMed Central

21 September 2017

J Charles Whitbeck

3

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

328

1 reference

Europe PubMed Central

21 September 2017

1

1 reference

Europe PubMed Central

21 September 2017

30-35

1 reference

Europe PubMed Central

21 September 2017

The nature of the immune state produced by inactivated vaccinia virus in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Smallpox vaccination: a review, part II. Adverse events

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

The looming threat of bioterrorism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Extracellular enveloped vaccinia virus escapes neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Inhibition of the complement cascade by the major secretory protein of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Antibody neutralization of the extracellular enveloped form of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

The formation and function of extracellular enveloped vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Inactivated Smallpox Vaccine: Immunogenicity of Inactivated Intracellular and Extracellular Vaccinia Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

Role of cell-associated enveloped vaccinia virus in cell-to-cell spread

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of heat-labile factors on the neutralization of vaccinia virus by human

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.024

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2004.07.024

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40513472&oldid=1899788586"